Corrigendum to “Proopiomelanocortin gene delivery induces apoptosis in melanoma through NADPH oxidase 4-mediated ROS generation” [Free Radic. Biol. Med. 70 (2014) 14–22] (Free Radical Biology and Medicine (2014) 70 (14–22), (S0891584913015657), (10.1016/j.freeradbiomed.2013.12.024));Proopiomelanocortin gene delivery induces apoptosis in melanoma through NADPH oxidase 4-mediated ROS generation

Free Radical Biology and Medicine

Volumn 70, Issue , 2014, Pages 14-22

  Liu, Guei Sheung ^a,b   Wu, Jian Ching ^c   Tsai, Han En ^c   Dusting, Gregory J ^a,b   Chan, Elsa C ^a,b   Wu, Chieh Shan ^d   Tai, Ming Hong ^c  

^a CENTRE FOR EYE RESEARCH AUSTRALIA   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^d KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Free radicals; Melanoma; NADPH oxidase; POMC; ROS

Indexed keywords

ACETYLCYSTEINE; ADENOVIRUS VECTOR; ALPHA INTERMEDIN; BETA INTERMEDIN; CASPASE 3; COBALT CHLORIDE; CORTICOTROPIN; DIPHENYLIODONIUM SALT; GAMMA INTERMEDIN; PROOPIOMELANOCORTIN; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; NOX4 PROTEIN, MOUSE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BLOOD VESSEL; CANCER GENE THERAPY; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE SILENCING; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MELANOMA; MOUSE; NICK END LABELING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; ANIMAL; GENE THERAPY; GENE TRANSFER; GENETICS; MELANOMA, EXPERIMENTAL; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; APOPTOSIS; CASPASE 3; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; MELANOMA, EXPERIMENTAL; MICE; NADPH OXIDASE; PRO-OPIOMELANOCORTIN; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84896784375     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2020.06.012     Document Type: Erratum

References (38)

1. C.Z. Michaylira, and H. Nakagawa Hypoxic microenvironment as a cradle for melanoma development and progression Cancer Biol. Ther. 5 2006 476 479
2. P. Vaupel, and A. Mayer Hypoxia in cancer: significance and impact on clinical outcome Cancer Metastasis Rev. 26 2007 225 239
3. E. Lartigau, H. Randrianarivelo, M.F. Avril, A. Margulis, A. Spatz, F. Eschwege, and M. Guichard Intratumoral oxygen tension in metastatic melanoma Melanoma Res. 7 1997 400 406
4. T.G. Graeber, C. Osmanian, T. Jacks, D.E. Housman, C.J. Koch, S.W. Lowe, and A.J. Giaccia Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours Nature 379 1996 88 91
5. E.K. Rofstad, and T. Danielsen Hypoxia-induced angiogenesis and vascular endothelial growth factor secretion in human melanoma Br. J. Cancer 77 1998 897 902
6. T. Finkel Signal transduction by reactive oxygen species J. Cell Biol. 194 2011 7 15
7. J.P. Fruehauf, and F.L. Meyskens Jr. Reactive oxygen species: a breath of life or death? Clin. Cancer Res. 13 2007 789 794
8. R.D. Guzy, and P.T. Schumacker Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia Exp. Physiol. 91 2006 807 819
9. N.S. Chandel, E. Maltepe, E. Goldwasser, C.E. Mathieu, M.C. Simon, and P.T. Schumacker Mitochondrial reactive oxygen species trigger hypoxia-induced transcription Proc. Natl. Acad. Sci. USA 95 1998 11715 11720
10. A. Galanis, A. Pappa, A. Giannakakis, E. Lanitis, D. Dangaj, and R. Sandaltzopoulos Reactive oxygen species and HIF-1 signalling in cancer Cancer Lett. 266 2008 12 20
11. C. Fleury, B. Mignotte, and J.L. Vayssiere Mitochondrial reactive oxygen species in cell death signaling Biochimie 84 2002 131 141
12. C. Brenner, and S. Grimm The permeability transition pore complex in cancer cell death Oncogene 25 2006 4744 4756
13. M.L. Raffin-Sanson, Y. de Keyzer, and X. Bertagna Proopiomelanocortin, a polypeptide precursor with multiple functions: from physiology to pathological conditions Eur. J. Endocrinol. 149 2003 79 90
14. A.S. Garfield, D.D. Lam, O.J. Marston, M.J. Przydzial, and L.K. Heisler Role of central melanocortin pathways in energy homeostasis Trends Endocrinol. Metab. 20 2009 203 215
15. K.M. Hegadoren, T. O'Donnell, R. Lanius, N.J. Coupland, and N. Lacaze-Masmonteil The role of beta-endorphin in the pathophysiology of major depression Neuropeptides 43 2009 341 353
16. K. Rousseau, S. Kauser, L.E. Pritchard, A. Warhurst, R.L. Oliver, A. Slominski, E.T. Wei, A.J. Thody, D.J. Tobin, and A. White Proopiomelanocortin (POMC), the ACTH/melanocortin precursor, is secreted by human epidermal keratinocytes and melanocytes and stimulates melanogenesis FASEB J 21 2007 1844 1856
17. K. Smalley, and T. Eisen The involvement of p38 mitogen-activated protein kinase in the alpha-melanocyte stimulating hormone (alpha-MSH)-induced melanogenic and anti-proliferative effects in B16 murine melanoma cells FEBS Lett 476 2000 198 202
18. J. Murata, K. Ayukawa, M. Ogasawara, H. Fujii, and I. Saiki Alpha-melanocyte-stimulating hormone blocks invasion of reconstituted basement membrane (Matrigel) by murine B16 melanoma cells Invasion Metastasis 17 1997 82 93
19. G.S. Liu, H.E. Tsai, W.T. Weng, L.F. Liu, C.H. Weng, M.R. Chuang, H.C. Lam, C.S. Wu, R. Tee, Z.H. Wen, S.L. Howng, and M.H. Tai Systemic pro-opiomelanocortin expression induces melanogenic differentiation and inhibits tumor angiogenesis in established mouse melanoma Hum. Gene Ther. 22 2011 325 335
20. H.E. Tsai, G.S. Liu, M.L. Kung, L.F. Liu, J.C. Wu, C.H. Tang, C.H. Huang, S.C. Chen, H.C. Lam, C.S. Wu, and M.H. Tai Downregulation of hepatoma-derived growth factor contributes to retarded lung metastasis via inhibition of epithelial-mesenchymal transition by systemic POMC gene delivery in melanoma Mol. Cancer Ther 12 2013 1016 1025
21. H.E. Tsai, L.F. Liu, G.J. Dusting, W.T. Weng, S.C. Chen, M.L. Kung, R. Tee, G.S. Liu, and M.H. Tai Pro-opiomelanocortin gene delivery suppresses the growth of established Lewis lung carcinoma through a melanocortin-1 receptor-independent pathway J. Gene Med. 14 2012 44 53
22. G.S. Liu, L.F. Liu, C.J. Lin, J.C. Tseng, M.J. Chuang, H.C. Lam, J.K. Lee, L.C. Yang, J.H. Chan, S.L. Howng, and M.H. Tai Gene transfer of pro-opiomelanocortin prohormone suppressed the growth and metastasis of melanoma: involvement of alpha-melanocyte-stimulating hormone-mediated inhibition of the nuclear factor kappaB/cyclooxygenase-2 pathway Mol. Pharmacol. 69 2006 440 451
23. S.T. Hsiao, Z. Lokmic, H. Peshavariya, K.M. Abberton, G.J. Dusting, S.Y. Lim, and R.J. Dilley Hypoxic conditioning enhances the angiogenic paracrine activity of human adipose-derived stem cells Stem Cells Dev. 22 2013 1614 1623
24. G.S. Liu, H. Peshavariya, M. Higuchi, A.C. Brewer, C.W. Chang, E.C. Chan, and G.J. Dusting Microphthalmia-associated transcription factor modulates expression of NADPH oxidase type 4: a negative regulator of melanogenesis Free Radic. Biol. Med. 52 2012 1835 1843
25. P. Zhang, W. Li, L. Li, N. Wang, X. Li, M. Gao, J. Zheng, S. Lei, X. Chen, H. Lu, and Y. Liu Treatment with edaravone attenuates ischemic brain injury and inhibits neurogenesis in the subventricular zone of adult rats after focal cerebral ischemia and reperfusion injury Neuroscience 201 2012 297 306
26. M. Tochigi, T. Inoue, M. Suzuki-Karasaki, T. Ochiai, C. Ra, and Y. Suzuki-Karasaki Hydrogen peroxide induces cell death in human TRAIL-resistant melanoma through intracellular superoxide generation Int. J. Oncol. 42 2013 863 872
27. H.G. Wittgen, and L.C. van Kempen Reactive oxygen species in melanoma and its therapeutic implications Melanoma Res. 17 2007 400 409
28. P. Valverde, P. Manning, C.J. McNeil, and A.J. Thody Activation of tyrosinase reduces the cytotoxic effects of the superoxide anion in B16 mouse melanoma cells Pigm. Cell Res. 9 1996 77 84
29. M. Barbi de Moura, G. Vincent, S.L. Fayewicz, N.W. Bateman, B.L. Hood, M. Sun, J. Suhan, S. Duensing, Y. Yin, C. Sander, J.M. Kirkwood, D. Becker, T.P. Conrads, B. Van Houten, and S.J. Moschos Mitochondrial respiration - an important therapeutic target in melanoma PLoS One 7 2012 e40690
30. C. Denkert, M. Kobel, S. Berger, A. Siegert, A. Leclere, U. Trefzer, and S. Hauptmann Expression of cyclooxygenase 2 in human malignant melanoma Cancer Res. 61 2001 303 308
31. S.S. Brar, T.P. Kennedy, A.B. Sturrock, T.P. Huecksteadt, M.T. Quinn, A.R. Whorton, and J.R. Hoidal An NAD(P)H oxidase regulates growth and transcription in melanoma cells Am. J. Physiol. Cell Physiol 282 2002 C1212 1224
32. B. Bedogni, and M.B. Powell Hypoxia, melanocytes and melanoma - survival and tumor development in the permissive microenvironment of the skin Pigm. Cell Melanoma Res 22 2009 166 174
33. J.H. Lee, Y.S. Won, K.H. Park, M.K. Lee, H. Tachibana, K. Yamada, and K.I. Seo Celastrol inhibits growth and induces apoptotic cell death in melanoma cells via the activation ROS-dependent mitochondrial pathway and the suppression of PI3K/AKT signaling Apoptosis 17 2012 1275 1286
34. E. Mayola, C. Gallerne, D.D. Esposti, C. Martel, S. Pervaiz, L. Larue, B. Debuire, A. Lemoine, C. Brenner, and C. Lemaire Withaferin A induces apoptosis in human melanoma cells through generation of reactive oxygen species and down-regulation of Bcl-2 Apoptosis 16 2011 1014 1027
35. M. Yamaura, J. Mitsushita, S. Furuta, Y. Kiniwa, A. Ashida, Y. Goto, W.H. Shang, M. Kubodera, M. Kato, M. Takata, T. Saida, and T. Kamata NADPH oxidase 4 contributes to transformation phenotype of melanoma cells by regulating G2-M cell cycle progression Cancer Res. 69 2009 2647 2654
36. Y. Zhao, J. Liu, and K.E. McMartin Inhibition of NADPH oxidase activity promotes differentiation of B16 melanoma cells Oncol. Rep. 19 2008 1225 1230
37. M. Lasaga, L. Debeljuk, D. Durand, T.N. Scimonelli, and C. Caruso Role of alpha-melanocyte stimulating hormone and melanocortin 4 receptor in brain inflammation Peptides 29 2008 1825 1835
38. C. Bertolotto, P. Abbe, T.J. Hemesath, K. Bille, D.E. Fisher, J.P. Ortonne, and R. Ballotti Microphthalmia gene product as a signal transducer in cAMP-induced differentiation of melanocytes J. Cell Biol. 142 1998 827 835